You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ABUS Exercise Disclosure
Androski Lindsay · SEC Form 4 · Filed Sep 23, 2026
Exercise
Calculated transaction value
$0
Androski Lindsay President And CEO
Transaction date
Sep 18, 2026
Public filing date
Sep 23, 2026
Filing lag
Filed 5 days later
ABUS daily price context
Close on/before transaction
$5.01
Sep 18, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Shares
- Quantity / price
- 116,408 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001447028-26-000053
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$836.82K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Arbutus Biopharma Corp ABUS | Exercise | Sep 18, 2026 | $45.9K |
| Arbutus Biopharma Corp ABUS | Disposition | Sep 18, 2026 | $418.41K |
| Arbutus Biopharma Corp ABUS Current | Exercise | Sep 18, 2026 | $0 |
| Arbutus Biopharma Corp ABUS | Exercise | Sep 18, 2026 | $0 |
| Arbutus Biopharma Corp ABUS | Exercise | Sep 18, 2026 | $372.51K |